Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms RSS Feed RSS Feeds


Press Release

Obalon Therapeutics To Present at Two Upcoming Investor Conferences

Posted on: 14 Nov 16

SAN DIEGO, Nov. 14, 2016 (GLOBE NEWSWIRE) -- Obalon Therapeutics, Inc. (NASDAQ:OBLN), a vertically integrated medical technology company with the first and only FDA-approved swallowable, gas-filled intragastric balloon system for the treatment of obesity, today announced that Andy Rasdal, Chief Executive Officer and Bill Plovanic, Chief Financial Officer of Obalon will present at two upcoming investor conferences:

  • Stifel 2016 Healthcare Conference
    Wednesday, November 16, 2016 at 8:00 a.m. Eastern Time
    Lotte New York Palace Hotel, New York, NY
    Webcast Available at:

  • Canaccord Genuity Medical Technologies & Diagnostics Forum
    Thursday, November 17, 2016 at 4:00 p.m. Eastern Time
    Westin Grand Central, New York, NY
    Webcast Available at:

Live audio webcasts of the presentations can be accessed at the links above. Replays of the webcasts will be available for 90 days following each presentation.

About Obalon Therapeutics, Inc.
Obalon Therapeutics, Inc. (NASDAQ:OBLN), is a San Diego-based company focused on developing and commercializing novel technologies for weight loss. The Obalon management team has over 150 combined years of experience in developing and commercializing novel medical technologies with a track record of financial and clinical excellence. For more information, please visit


Last updated on: 14/11/2016

Site Map | Privacy & Security | Cookies | Terms and Conditions is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.